Market Opportunity

As population demographics shift and sporting activities and levels of obesity rise, the incidence of degenerative joint disease is increasing. Indeed data suggests that by 2030, the incidence of osteoarthritis will increase by 40%.

Degenerative joint disease is a leading cause of work disability and reduced quality of life. The pressure on healthcare systems to control symptoms and help patients remain active in the years ahead will be immense.

Orthomimetics has developed unique biological solutions to restore joint mobility and prevent the onset of degenerative joint disease. In sports medicine, the market for regenerative repair to cartilage, ligaments and tendons is estimated at $1 billion.

The proprietory material technology provides multiple clinical benefits and offers significant competitive advantage and strong growth potential in a sector largely unaddressed by major orthopaedic companies.